Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Cancer > Haematological malignancies > Chronic lymphocytic leukaemia

Published:

28 December 2016

Authors:

Villarroel Gonzalez D, Elter T, Monsef I, Engert A, Skoetz N

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Villarroel Gonzalez D, Elter T, Monsef I, Engert A, Skoetz N. Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No.: CD010124. DOI: 10.1002/14651858.CD010124.pub2